BMEA
Price
$1.62
Change
+$0.10 (+6.58%)
Updated
Jan 14 closing price
Capitalization
114.89M
81 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$17.42
Change
+$0.32 (+1.87%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.23B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMEA vs MLTX

Header iconBMEA vs MLTX Comparison
Open Charts BMEA vs MLTXBanner chart's image
Biomea Fusion
Price$1.62
Change+$0.10 (+6.58%)
Volume$2.38M
Capitalization114.89M
MoonLake Immunotherapeutics
Price$17.42
Change+$0.32 (+1.87%)
Volume$39.1K
Capitalization1.23B
BMEA vs MLTX Comparison Chart in %
BMEA
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMEA vs. MLTX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and MLTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (BMEA: $1.62 vs. MLTX: $17.41)
Brand notoriety: BMEA and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 173% vs. MLTX: 74%
Market capitalization -- BMEA: $114.89M vs. MLTX: $1.23B
BMEA [@Biotechnology] is valued at $114.89M. MLTX’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, MLTX is a better buy in the long-term than BMEA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • BMEA’s TA Score: 5 bullish, 4 bearish.
  • MLTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BMEA is a better buy in the short-term than MLTX.

Price Growth

BMEA (@Biotechnology) experienced а +21.80% price change this week, while MLTX (@Biotechnology) price change was +54.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

BMEA is expected to report earnings on Apr 06, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($1.23B) has a higher market cap than BMEA($115M). BMEA (30.645) and MLTX (29.742) have similar YTD gains . BMEA has higher annual earnings (EBITDA): -97.83M vs. MLTX (-227.94M). MLTX has more cash in the bank: 380M vs. BMEA (46.6M). BMEA has less debt than MLTX: BMEA (6.88M) vs MLTX (75.7M). BMEA (0) and MLTX (0) have equivalent revenues.
BMEAMLTXBMEA / MLTX
Capitalization115M1.23B9%
EBITDA-97.83M-227.94M43%
Gain YTD30.64529.742103%
P/E RatioN/AN/A-
Revenue00-
Total Cash46.6M380M12%
Total Debt6.88M75.7M9%
TECHNICAL ANALYSIS
Technical Analysis
BMEAMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TWIRF1.920.04
+1.91%
Tree Island Steel Ltd.
KAOOY7.840.01
+0.13%
Kao Corp.
ARCAY47.00N/A
N/A
Arcadis NV
QNICF0.14N/A
N/A
QUEBEC NICKEL CORP.
ELTP0.48N/A
-0.73%
Elite Pharmaceuticals, Inc.

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with TCRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+6.58%
TCRX - BMEA
38%
Loosely correlated
+2.56%
VYGR - BMEA
37%
Loosely correlated
+2.74%
SYRE - BMEA
36%
Loosely correlated
+5.17%
MLTX - BMEA
36%
Loosely correlated
+1.81%
AGEN - BMEA
36%
Loosely correlated
+1.52%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-5.47%
KALA - MLTX
84%
Closely correlated
-4.83%
IOBT - MLTX
73%
Closely correlated
+2.17%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-1.62%
NUVL - MLTX
48%
Loosely correlated
+2.03%
More